Searched over 200M research papers
10 papers analyzed
Some studies suggest intravenous iron is more effective and better tolerated for treating anemia in adults with inflammatory bowel disease and non-anaemic iron deficiency, while other studies indicate it may have higher potential harms and costs compared to oral iron in adults and children with chronic kidney disease.
19 papers analyzed
Anemia is a common complication in adults with inflammatory bowel disease (IBD). Research comparing intravenous (IV) and oral iron supplementation shows that IV iron is more effective in increasing hemoglobin levels by at least 2.0 g/dL compared to oral iron. Additionally, IV iron is associated with fewer gastrointestinal side effects and lower treatment discontinuation rates due to adverse events. However, serious adverse events, though rare, were more frequently reported in patients receiving IV iron.
In adults with chronic kidney disease (CKD), both IV and oral iron are used to manage anemia. Studies indicate that IV iron may increase hemoglobin, ferritin, and transferrin saturation levels more effectively than oral iron . IV iron also reduces the required dose of erythropoiesis-stimulating agents (ESAs) . However, there is insufficient evidence to determine if IV iron impacts mortality, cardiovascular death, or quality of life significantly. Gastrointestinal side effects are more common with oral iron, while allergic reactions and hypotension are more frequent with IV iron.
Iron absorption varies significantly between individuals. Normal iron-replete adults absorb about 10% of orally administered iron, while iron-deficient individuals can absorb between 29% and 71%. This variability underscores the importance of choosing the appropriate iron supplementation method based on individual iron status.
For non-anemic iron-deficient adults, IV iron has been shown to improve physical function and reduce fatigue, although the overall quality of evidence is low . IV iron increases serum ferritin and hemoglobin levels more effectively than placebo . However, the evidence is insufficient to draw definitive conclusions about its impact on quality of life and other patient-centric outcomes.
Iron deficiency, particularly in the brain, is implicated in the pathophysiology of Restless Legs Syndrome (RLS). IV iron, specifically ferric carboxymaltose, is effective in treating moderate to severe RLS in adults with low serum ferritin levels. Oral iron is possibly effective for those with serum ferritin ≤75 µg/L, but more research is needed to confirm its efficacy in children.
Oral iron, particularly ferrous sulfate, is associated with significant gastrointestinal side effects, including nausea, abdominal pain, and constipation. These side effects are more pronounced compared to IV iron, which may lead to better adherence to IV iron therapy in some patients.
Novel iron supplements, such as nanoparticulate iron hydroxide adipate tartrate (IHAT) and iron-enriched Aspergillus oryzae product (ASP), have been tested for safety in healthy adults. These supplements did not significantly affect primary safety endpoints like susceptibility to malarial infection or bacterial proliferation. However, gastrointestinal symptoms were more frequently reported with IHAT and ASP compared to ferrous sulfate.
Vegetarian diets, which exclude meat and seafood, are associated with lower serum ferritin levels compared to non-vegetarian diets. This is due to the absence of highly bioavailable heme iron and the presence of inhibitors of non-heme iron absorption in plant-based foods. Regular monitoring of iron status and dietary adjustments are recommended for vegetarians to prevent iron deficiency.
In summary, IV iron is generally more effective and better tolerated than oral iron for treating anemia in various conditions, including IBD and CKD. However, the choice between IV and oral iron should consider individual patient needs, potential side effects, and specific clinical scenarios. Novel iron supplements show promise but require further research to confirm their safety and efficacy. Regular monitoring and appropriate dietary adjustments are crucial for maintaining optimal iron levels, especially in populations at risk of deficiency, such as vegetarians.
Most relevant research papers on this topic